BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND TLX1, P31314, 3195, ENSG00000107807, TCL3, HOX11 AND Clinical Outcome
5 results:

  • 1. Epigenetic Silencing Affects l-Asparaginase Sensitivity and Predicts outcome in T-ALL.
    Touzart A; Lengliné E; Latiri M; Belhocine M; Smith C; Thomas X; Spicuglia S; Puthier D; Pflumio F; Leguay T; Graux C; Chalandon Y; Huguet F; Leprêtre S; Ifrah N; Dombret H; Macintyre E; Hunault M; Boissel N; Asnafi V
    Clin Cancer Res; 2019 Apr; 25(8):2483-2493. PubMed ID: 30659025
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. T cell receptor genotyping and HOXA/tlx1 expression define three T lymphoblastic lymphoma subsets which might affect clinical outcome.
    Baleydier F; Decouvelaere AV; Bergeron J; Gaulard P; Canioni D; Bertrand Y; Lepretre S; Petit B; Dombret H; Beldjord K; Molina T; Asnafi V; Macintyre E
    Clin Cancer Res; 2008 Feb; 14(3):692-700. PubMed ID: 18245528
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. clinical significance of hox11L2 expression linked to t(5;14)(q35;q32), of hox11 expression, and of SIL-TAL fusion in childhood T-cell malignancies: results of EORTC studies 58881 and 58951.
    Cavé H; Suciu S; Preudhomme C; Poppe B; Robert A; Uyttebroeck A; Malet M; Boutard P; Benoit Y; Mauvieux L; Lutz P; Méchinaud F; Grardel N; Mazingue F; Dupont M; Margueritte G; Pages MP; Bertrand Y; Plouvier E; Brunie G; Bastard C; Plantaz D; Vande Velde I; Hagemeijer A; Speleman F; Lessard M; Otten J; Vilmer E; Dastugue N;
    Blood; 2004 Jan; 103(2):442-50. PubMed ID: 14504110
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Expression of hox11 in childhood T-lineage acute lymphoblastic leukaemia can occur in the absence of cytogenetic aberration at 10q24: a study from the Children's Cancer Group (CCG).
    Kees UR; Heerema NA; Kumar R; Watt PM; Baker DL; La MK; Uckun FM; Sather HN
    Leukemia; 2003 May; 17(5):887-93. PubMed ID: 12750702
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. High serum interleukin-2 receptor levels correlate with a poor prognosis in children with Hodgkin's disease.
    Pui CH; Ip SH; Thompson E; Wilimas J; Brown M; Dodge RK; de Hoyos RA; Berard CW; Crist WM
    Leukemia; 1989 Jul; 3(7):481-4. PubMed ID: 2786597
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.